Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
29.54
+0.14 (0.48%)
At close: May 4, 2026, 4:00 PM EDT
29.15
-0.39 (-1.32%)
After-hours: May 4, 2026, 7:58 PM EDT
Rigel Pharmaceuticals Market Cap
Rigel Pharmaceuticals has a market cap or net worth of $545.9 million as of May 4, 2026. Its market cap has increased by 85.30% in one year.
Market Cap
545.90M
Enterprise Value
444.25M
1-Year Change
85.30%
Ranking
Category
Stock Price
$29.54
Market Cap Chart
Since November 29, 2000, Rigel Pharmaceuticals's market cap has increased from $254.90M to $545.90M, an increase of 114.16%. That is a compound annual growth rate of 3.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 543.10M | -30.14% |
| Dec 31, 2025 | 777.40M | 162.37% |
| Dec 31, 2024 | 296.30M | 17.21% |
| Dec 29, 2023 | 252.80M | -2.51% |
| Dec 30, 2022 | 259.30M | -42.78% |
| Dec 31, 2021 | 453.20M | -23.37% |
| Dec 31, 2020 | 591.40M | 64.87% |
| Dec 31, 2019 | 358.70M | -6.42% |
| Dec 31, 2018 | 383.30M | -32.57% |
| Dec 29, 2017 | 568.40M | 141.36% |
| Dec 30, 2016 | 235.50M | -12.19% |
| Dec 31, 2015 | 268.20M | 34.57% |
| Dec 31, 2014 | 199.30M | -20.02% |
| Dec 31, 2013 | 249.20M | -55.93% |
| Dec 31, 2012 | 565.50M | 0.60% |
| Dec 30, 2011 | 562.10M | 43.14% |
| Dec 31, 2010 | 392.70M | -20.31% |
| Dec 31, 2009 | 492.80M | 68.36% |
| Dec 31, 2008 | 292.70M | -62.86% |
| Dec 31, 2007 | 788.20M | 164.67% |
| Dec 29, 2006 | 297.80M | 47.43% |
| Dec 30, 2005 | 202.00M | -57.71% |
| Dec 31, 2004 | 477.70M | 68.26% |
| Dec 31, 2003 | 283.90M | 465.54% |
| Dec 31, 2002 | 50.20M | -71.28% |
View and export this data all the way back to 2000. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Altimmune | 578.71M |
| Prothena Corporation | 578.17M |
| Tectonic Therapeutic | 566.59M |
| Entrada Therapeutics | 564.85M |
| AgomAb Therapeutics NV | 562.91M |
| MiMedx Group | 546.63M |
| Eikon Therapeutics | 545.18M |
| Shattuck Labs | 540.41M |